Medicine, Hematology Oncology Division

Research Output

Filter
Letter
2020

Disclose and Manage Conflicts of Interest at Cancer Centers

Jensen, R. A., Knudsen, K. E. & Platanias, L. C., Jan 2020, In : JAMA internal medicine. 180, 1, 1 p.

Research output: Contribution to journalLetter

2019

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

Johnson, D. B., McDonnell, W. J., Gonzalez-Ericsson, P. I., Al-Rohil, R. N., Mobley, B. C., Salem, J. E., Wang, D. Y., Sanchez, V., Wang, Y., Chastain, C. A., Barker, K., Liang, Y., Warren, S., Beechem, J. M., Menzies, A. M., Tio, M., Long, G. V., Cohen, J. V., Guidon, A. C., O’Hare, M. & 13 others, Chandra, S., Chowdhary, A., Lebrun-Vignes, B., Goldinger, S. M., Rushing, E. J., Buchbinder, E. I., Mallal, S. A., Shi, C., Xu, Y., Moslehi, J. J., Sanders, M. E., Sosman, J. A. & Balko, J. M., Aug 1 2019, In : Nature Medicine. 25, 8, p. 1243-1250 8 p.

Research output: Contribution to journalLetter

17 Scopus citations

Adverse Events Associated with Immune Checkpoint Inhibitors - Reply

Johnson, D. B., Chandra, S. & Sosman, J. A., Mar 26 2019, In : JAMA - Journal of the American Medical Association. 321, 12, p. 1219-1220 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression

Xu, B., Song, B., Lu, X., Kim, J., Hu, M., Zhao, J. C. & Yu, J., Sep 1 2019, In : Cell Research. 29, 9, p. 773-775 3 p.

Research output: Contribution to journalLetter

2 Scopus citations

A Time to Ignore “No Meat, No Treat”

Kruser, T. J. & Sosman, J. A., Oct 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 2, p. 245-246 2 p.

Research output: Contribution to journalLetter

Mitochondrial complex III is essential for suppressive function of regulatory T cells

Weinberg, S. E., Singer, B. D., Steinert, E. M., Martinez, C. A., Mehta, M. M., Martínez-Reyes, I., Gao, P., Helmin, K. A., Abdala-Valencia, H., Sena, L. A., Schumacker, P. T., Turka, L. A. & Chandel, N. S., Jan 24 2019, In : Nature. 565, 7740, p. 495-499 5 p.

Research output: Contribution to journalLetter

54 Scopus citations

Palbociclib and Fulvestrant in Breast Cancer. Reply

Turner, N. C., Huang, X. & Cristofanilli, M., Feb 21 2019, In : The New England journal of medicine. 380, 8, 1 p.

Research output: Contribution to journalLetter

2 Scopus citations

The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors

Copeland, A. C., Foster, M. C., Muluneh, B., Xenakis, J. G., Ivanova, A., Frankfurt, O., Clayton, M., Black, A., Rapchak, B. & Wehbie, R. S., Jun 7 2019, In : Leukemia and Lymphoma. 60, 7, p. 1842-1844 3 p.

Research output: Contribution to journalLetter

2018

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

Moslehi, J. J., Salem, J. E., Sosman, J. A., Lebrun-Vignes, B. & Johnson, D. B., Mar 10 2018, In : The Lancet. 391, 10124, 1 p.

Research output: Contribution to journalLetter

179 Scopus citations

In reply

Stein, B., DeCredico, N. & Hillman, L., Sep 11 2018, In : JAMA - Journal of the American Medical Association. 320, 10, 1 p.

Research output: Contribution to journalLetter

Regarding the Congruence between 2 Circulating Tumor DNA Sequencing Assays

Rolfo, C., Raez, L. & Cristofanilli, M., Oct 2018, In : JAMA Oncology. 4, 10, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

Reporting of immune checkpoint inhibitor-associated myocarditis – Authors' reply

Moslehi, J. J., Salem, J. E., Sosman, J. A., Lebrun-Vignes, B. & Johnson, D. B., Aug 4 2018, In : The Lancet. 392, 10145, p. 384-385 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
5 Scopus citations

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL

Galanina, N., Smith, S. M., Liao, C., Petrich, A., Libao, B., Gartenhaus, R., Westin, J. R., Cohen, K. S., Knost, J. A., Stadler, W. M., Doyle, A., Karrison, T., Gordon, L. I. & Evens, A. M., Apr 2018, In : British Journal of Haematology. 181, 2, p. 264-267 4 p.

Research output: Contribution to journalLetter

2017

ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia

Sun, X., Lu, B., Han, C., Qiu, W., Jin, Q., Li, D., Li, Q., Yang, Q., Wen, Q., Opal, P., Kini, A. R., Crispino, J. D. & Huang, Z., Dec 1 2017, In : Blood cancer journal. 7, 12, 31.

Research output: Contribution to journalLetter

2 Scopus citations

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Kongtim, P., Adekola, K., Milton, D. R., Ramlal, R., Jimenez, A., Chen, J., Rondon, G., Ahmed, S., Kebriaei, P., Betul, O., Hosing, C. M., Popat, U., Khouri, I., Jabbour, E., Cortes, J. E., Kantarjian, H. M., Champlin, R. E. & Ciurea, S. O., Jul 1 2017, In : Leukemia. 31, 7, p. 1654-1657 4 p.

Research output: Contribution to journalLetter

4 Scopus citations

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

Swords, R. T., Watts, J., Erba, H. P., Altman, J. K., Maris, M., Anwer, F., Hua, Z., Stein, H., Faessel, H., Sedarati, F., Dezube, B. J., Giles, F. J., Medeiros, B. C. & DeAngelo, D. J., Feb 3 2017, In : Blood cancer journal. 7, 2, e520.

Research output: Contribution to journalLetter

14 Scopus citations

In reply

Gradishar, W., Brown, K., Mundt, E. & Manley, S., Dec 2017, In : Oncologist. 22, 12, 1 p.

Research output: Contribution to journalLetter

It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma

Elimova, E., Janjigian, Y. Y., Mulcahy, M. F., Catenacci, D. V., Blum, M. A., Almhanna, K., Hecht, J. R. & Ajani, J. A., Feb 1 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 4, p. 475-477 3 p.

Research output: Contribution to journalLetter

12 Scopus citations

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

Smith, M. R., Hong, F., Li, H., Gordon, L. I., Gascoyne, R. D., Paietta, E. M., Advani, R. H., Forero-Torres, A., Horning, S. J. & Kahl, B. S., Feb 1 2017, In : Leukemia. 31, 2, p. 517-519 3 p.

Research output: Contribution to journalLetter

6 Scopus citations

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

Pro, B., Horwitz, S. M., Prince, H. M., Foss, F. M., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Wilhelm, M., Iyer, S. P., Shustov, A. R., Wolfson, J., Balser, B. E. & Coiffier, B., Dec 2017, In : Hematological Oncology. 35, 4, p. 914-917 4 p.

Research output: Contribution to journalLetter

11 Scopus citations

The authors reply

Moslehi, J. J., Johnson, D. B. & Sosman, J. A., Jan 19 2017, In : New England Journal of Medicine. 376, 3, 1 p.

Research output: Contribution to journalLetter

5 Scopus citations
2016

Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum

Johnson, D. B., Roszik, J., Shoushtari, A. N., Eroglu, Z., Balko, J. M., Higham, C., Puzanov, I., Patel, S. P., Sosman, J. A. & Woodman, S. E., Jul 1 2016, In : Pigment Cell and Melanoma Research. 29, 4, p. 470-473 4 p.

Research output: Contribution to journalLetter

9 Scopus citations

Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide

Rifkin, R. M., Abonour, R., Shah, J. J., Mehta, J., Narang, M., Terebelo, H., Gasparetto, C., Toomey, K., Hardin, J. W., Lu, J. J., Kenvin, L., Srinivasan, S., Knight, R., Nagarwala, Y. & Durie, B. G. M., Sep 1 2016, In : Leukemia and Lymphoma. 57, 9, p. 2228-2231 4 p.

Research output: Contribution to journalLetter

14 Scopus citations

Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial

Karuturi, M., Younes, A., Fayad, L., Kwak, L., Pro, B., Shah, J., Oki, Y., Simien, R., Liboon, M. J., Hutto, T., Feng, L., Horowitz, S., Nieto, Y., Anderlini, P., Alousi, A., Popat, U., Medeiros, L. J., Miranda, R. & Fanale, M., Feb 1 2016, In : Leukemia and Lymphoma. 57, 2, p. 445-447 3 p.

Research output: Contribution to journalLetter

2 Scopus citations

Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacy

Martin, K., Kasthuri, R., Mooberry, M. J., Chen, S. L., Key, N. S. & Ma, A. D., Nov 1 2016, In : Haemophilia. 22, 6, p. e549-e551

Research output: Contribution to journalLetter

2 Scopus citations

Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., Yu, X. & 3 others, Nava-Parada, P., Mei, J. & Kipps, T. J., Jan 1 2016, In : Haematologica. 101, 7, p. e295-e298

Research output: Contribution to journalLetter

26 Scopus citations

Reexamining the ecology of medical care

Johansen, M. E., Kircher, S. M. & Huerta, T. R., Feb 4 2016, In : New England Journal of Medicine. 374, 5, p. 495-496 2 p.

Research output: Contribution to journalLetter

13 Scopus citations
2015

Bevacizumab for recurrent primary central nervous system lymphoma: A new treatment?

Nieto, K., Gordon, L. I. & Raizer, J., Jan 1 2015, In : Neuro-oncology. 17, 12, p. 1648-1649 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Disclosure of boxed warnings to research participants

Bhattacharya, T., Tice, D. G., Lingam, P., Florek, A., Yates, E. M., Weitzman, S. & Belknap, S. M., Sep 1 2015, In : JAMA internal medicine. 175, 9, p. 1567-1568 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors

Ammakkanavar, N. R., Matei, D., Abonour, R. & Einhorn, L. H., Oct 10 2015, In : Journal of Clinical Oncology. 33, 2, p. 226-227 2 p.

Research output: Contribution to journalLetter

13 Scopus citations

Oral health in oncology: impact of immunotherapy

Jackson, L. K., Johnson, D. B., Sosman, J. A., Murphy, B. A. & Epstein, J. B., Jan 1 2015, In : Supportive Care in Cancer. 23, 1, p. 1-3 3 p.

Research output: Contribution to journalLetter

11 Scopus citations

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

Turner, N. C., Huang Bartlett, C. & Cristofanilli, M., Oct 22 2015, In : The New England journal of medicine. 373, 17, p. 1672-1673 2 p.

Research output: Contribution to journalLetter

Re: Confronting oncologists’ emotions

Morgans, A. & Schapira, L., Dec 1 2015, In : Oncologist. 20, 12, 1 p.

Research output: Contribution to journalLetter

Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts

Tabarroki, A., Saunthararajah, Y., Visconte, V., Cinalli, T., Colaluca, K., Rogers, H. J., Sekeres, M. A., Duong, H. K., Stein, B. L. & Tiu, R. V., Feb 1 2015, In : Leukemia and Lymphoma. 56, 2, p. 497-499 3 p.

Research output: Contribution to journalLetter

13 Scopus citations

Telomere length at diagnosis of chronic phase chronic myeloid leukemia (CML-CP) identifies a subgroup with favourable prognostic parameters and molecular response according to the ELN criteria after 12 months of treatment with nilotinib

Wenn, K., Tomala, L., Wilop, S., Vankann, L., Hasenbank, C., Frank, O., Hochhaus, A., Giles, F. J., Lange, T., Müller, M. C., Koschmieder, S., Beier, F., Ziegler, P. & Brümmendorf, T. H., Dec 1 2015, In : Leukemia. 29, 12, p. 2402-2404 3 p.

Research output: Contribution to journalLetter

5 Scopus citations

The authors reply

Turner, N. C., Bartlett, C. H. & Cristofanilli, M., Oct 22 2015, In : New England Journal of Medicine. 373, 17, p. 1672-1673 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2014
2 Scopus citations

Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney disease

Tabarroki, A., Visconte, V., Rogers, H. J., Sekeres, M. A., Samaras, C., Lichtin, A., Duong, H. K., Englehaupt, R., Cinalli, T., Dodd, K., Desamito, J., Rouphail, B., Altman, J. K., Stein, B. L. & Tiu, R. V., Jan 1 2014, In : Leukemia and Lymphoma. 55, 1, p. 213-216 4 p.

Research output: Contribution to journalLetter

2 Scopus citations

Drug allergy in haematopoietic stem cell transplantation

Gordon, J., Damstetter, E., Nardone, B., Mehta, J., West, D. P. & Cotliar, J., Jul 2014, In : Allergologia et Immunopathologia. 42, 4, p. 375-377 3 p.

Research output: Contribution to journalLetter

In reply to putnam

Hickey, R., Mulcahy, M. & Salem, R., Oct 1 2014, In : International Journal of Radiation Oncology Biology Physics. 90, 2, p. 473-474 2 p.

Research output: Contribution to journalLetter

Melanoma BRAF fusions-Response

Hutchinson, K. E., Ross, J. S., Stephens, P. J., Miller, V. A., Sosman, J. A. & Pao, W., Dec 15 2014, In : Clinical Cancer Research. 20, 24, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event

Gandhi, M. D., Evens, A. M., Fenske, T. S., Hamlin, P., Coiffier, B., Engert, A., Moskowitz, A. J., Ghosh, N., Petrich, A. M., Lomasney, J., Chadburn, A., Wood, G. S., Salva, K., Nardone, B., Trifilio, S. M., Raisch, D. W., West, D. P., Gordon, L. I. & Winter, J. N., May 1 2014, In : Blood. 123, 18, p. 2895-2897 3 p.

Research output: Contribution to journalLetter

35 Scopus citations

PARP inhibitors for chemoprevention - Letter

Chand, S. N., Blanco, F. F., Jimbo, M., Tsangaris, T. N., Cristofanilli, M., Yeo, C. J., Winter, J. M., Pishvaian, M. J. & Brody, J. R., Nov 1 2014, In : Cancer Prevention Research. 7, 11, p. 1170-1171 2 p.

Research output: Contribution to journalLetter

2 Scopus citations

Reply to C.C. Earle

Meyerhardt, J. A., Benson III, A. B. & Mangu, P. B., May 10 2014, In : Journal of Clinical Oncology. 32, 14, p. 1518-1519 2 p.

Research output: Contribution to journalLetter

Spindle cell squamous carcinoma during braf inhibitor therapy for advanced melanoma: An aggressive secondary neoplasm of undetermined biologic potential

Cohen, D. N., Lumbang, W. A., Boyd, A. S., Sosman, J. A. & Zwerner, J. P., Jan 1 2014, In : JAMA Dermatology. 150, 5, p. 575-577 3 p.

Research output: Contribution to journalLetter

7 Scopus citations

Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemia

Chae, Y. K., Trinh, L., Jain, P., Wang, X., Rozovski, U., Wierda, W. G., Keating, M. J. & Estrov, Z., Feb 27 2014, In : Blood. 123, 9, p. 1424-1426 3 p.

Research output: Contribution to journalLetter

13 Scopus citations
2013

Autoimmune haemophilia in a teenager

Batra, S., Sharathkumar, A., Glaubach, T., Gamerman, S. & Green, D., Nov 1 2013, In : Haemophilia. 19, 6, p. e386-e388

Research output: Contribution to journalLetter